Cargando…

Endogenous tumor-reactive CD8(+) T cells are differentiated effector cells expressing high levels of CD11a and PD-1 but are unable to control tumor growth

Immunotherapies aimed at enhancing natural or endogenous antitumor T-cell immunity in patients affected by advanced malignancies are currently being implemented in the clinic with promising results. In order to optimize therapeutic protocols and monitor the effectiveness of such therapies, reliable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xin, Gibbons, Rachel M., Harrington, Susan M., Krco, Christopher J., Markovic, Svetomir N., Kwon, Eugene D., Dong, Haidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716732/ https://www.ncbi.nlm.nih.gov/pubmed/23894697 http://dx.doi.org/10.4161/onci.23972

Ejemplares similares

Bim and PD-1 identify effector CD8 T cells responsive to anti-PD-1 therapy in metastatic melanoma patients
por: Dronca, Roxana, et al.
Publicado: (2015)

B7-H1 limits the entry of effector CD8(+) T cells to the memory pool by upregulating Bim
por: Gibbons, Rachel M., et al.
Publicado: (2012)

Effector CD4 and CD8 T Cells and Their Role in the Tumor Microenvironment
por: Hadrup, Sine, et al.
Publicado: (2012)

Tumor-specific CD4(+) T cells maintain effector and memory tumor-specific CD8(+) T cells
por: Church, Sarah E, et al.
Publicado: (2014)

PD-1 and ICOS coexpression identifies tumor-reactive CD4(+) T cells in human solid tumors
por: Duhen, Rebekka, et al.
Publicado: (2022)

Tumor-infiltrating CD62L(+)PD-1(-)CD8 T cells retain proliferative potential via Bcl6 expression and replenish effector T cells within the tumor
por: Gong, Yu, et al.
Publicado: (2020)

Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
por: Duhen, Thomas, et al.
Publicado: (2018)

CD103(+)CD8(+) T(RM) Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17
por: Corgnac, Stéphanie, et al.
Publicado: (2020)

CD80 Expressed by CD8(+) T Cells Contributes to PD-L1-Induced Apoptosis of Activated CD8(+) T Cells
por: Rollins, Meagan R., et al.
Publicado: (2017)

The Significance of Tumor Necrosis Factor Receptor Type II in CD8(+) Regulatory T Cells and CD8(+) Effector T Cells
por: Ye, Lin-Lin, et al.
Publicado: (2018)

CD4(+) cytotoxic T cells: an emerging effector arm of anti-tumor immunity
por: Jeong, Seongmin, et al.
Publicado: (2023)

Multimodal identification of rare potent effector CD8 T cells in solid tumors
por: Ray, Arja, et al.
Publicado: (2023)

Tumor Rejection Induced by CD70-mediated Quantitative and Qualitative Effects on Effector CD8(+) T Cell Formation
por: Arens, Ramon, et al.
Publicado: (2004)

Reduced CD5 on CD8(+) T Cells in Tumors but Not Lymphoid Organs Is Associated With Increased Activation and Effector Function
por: Alotaibi, Faizah, et al.
Publicado: (2021)

Reactivation of low avidity tumor-specific CD8(+) T cells associates with immunotherapeutic efficacy of anti-PD-1
por: Sugiyarto, Gessa, et al.
Publicado: (2023)

Depletion of Regulatory T Cells Induces High Numbers of Dendritic Cells and Unmasks a Subset of Anti-Tumour CD8(+)CD11c(+) PD-1(lo) Effector T Cells
por: Goudin, Nicolas, et al.
Publicado: (2016)

NKG2D defines tumor‐reacting effector CD8(+) T cells within tumor microenvironment
por: Mojic, Marija, et al.
Publicado: (2021)

B7-H1 antibodies lose antitumor activity due to activation of p38 MAPK that leads to apoptosis of tumor-reactive CD8(+) T cells
por: Liu, Xin, et al.
Publicado: (2016)

Correction: Depletion of Regulatory T Cells Induces High Numbers of Dendritic Cells and Unmasks a Subset of Anti-Tumour CD8(+)CD11c(+) PD-1(lo) Effector T Cells
por: Goudin, Nicolas, et al.
Publicado: (2017)

mTOR-dependent translation drives tumor infiltrating CD8(+) effector and CD4(+) Treg cells expansion
por: De Ponte Conti, Benedetta, et al.
Publicado: (2021)

HMGN2, a new anti-tumor effector molecule of CD8(+) T cells
por: Su, Lin, et al.
Publicado: (2014)

Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer
por: Kang, Chiao-Wen, et al.
Publicado: (2015)

Deletion of PTPN22 improves effector and memory CD8(+) T cell responses to tumors
por: Brownlie, Rebecca J., et al.
Publicado: (2019)

Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function
por: Dyck, Lydia, et al.
Publicado: (2022)

Correction: Reactivation of low avidity tumor-specific CD8+ T cells associates with immunotherapeutic efficacy of anti-PD-1
Publicado: (2023)

Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer Therapeutics
por: Enninga, Elizabeth Ann L., et al.
Publicado: (2015)

Early IL-10 promotes vasculature-associated CD4(+) T cells unable to control Mycobacterium tuberculosis infection
por: Ferreira, Catarina M., et al.
Publicado: (2021)

PD-L1 is expressed on human activated naive effector CD4(+) T cells. Regulation by dendritic cells and regulatory CD4(+) T cells
por: Mazerolles, Fabienne, et al.
Publicado: (2021)

Antibody-targeted paclitaxel loaded nanoparticles for the treatment of CD20(+) B-cell lymphoma
por: Nevala, Wendy K., et al.
Publicado: (2017)

PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1(hi)CD39(+) CD4 T cells
por: Balança, Camille-Charlotte, et al.
Publicado: (2021)

PD-L1, CD4+, and CD8+ Tumor-Infiltrating Lymphocytes (TILs) Expression Profiles in Melanoma Tumor Microenvironment Cells
por: Caraban, Bogdan Marian, et al.
Publicado: (2023)

Functional Change of Effector Tumor-Infiltrating CCR5(+)CD38(+)HLA-DR(+)CD8(+) T Cells in Glioma Microenvironment
por: Chen, Pin-Yuan, et al.
Publicado: (2019)

Self-Organized Criticality Theory and the Expansion of PD-1-Positive Effector CD4 T Cells: Search for Autoantibody-Inducing CD4 T Cells
por: Miyazaki, Yumi, et al.
Publicado: (2013)

Correction: Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function
por: Dyck, Lydia, et al.
Publicado: (2022)

Noninvasive interrogation of CD8(+) T cell effector function for monitoring early tumor responses to immunotherapy
por: Zhou, Haoyi, et al.
Publicado: (2022)

PD-1 blockade reverses viral infection-induced loss of anti-tumor CD8+ T cell responses
por: Huelsmann, Erica, et al.
Publicado: (2013)

Expansion of CD16-Negative Natural Killer Cells in the Peripheral Blood of Patients with Metastatic Melanoma
por: Holtan, Shernan G., et al.
Publicado: (2011)

Autoreactive Effector/Memory CD4(+) and CD8(+) T Cells Infiltrating Grafted and Endogenous Islets in Diabetic NOD Mice Exhibit Similar T Cell Receptor Usage
por: Diz, Ramiro, et al.
Publicado: (2012)

PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
por: Juneja, Vikram R., et al.
Publicado: (2017)

Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells
por: Sadeghlar, Farsaneh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uk66ta41l3euku5mijpedpga9b